The 35 references in paper T. Braunschweig, A. Lewandrowski, D. Smeets, M. Bolotin V., Т. Брауншвейг, А. Левандровски, Д. Смеетс, М. Болотин В. (2015) “ПЛОСКОКЛЕТОЧНЫЙ РАК ГОЛОВЫ И ШЕИ: НОВЫЕ ПЕРСПЕКТИВЫ ЛЕЧЕНИЯ? // SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?” / spz:neicon:ogsh:y:2013:i:3:p:4-10

1
Haddad R.I. and D.M. Shin. Recent advances in head and neck cancer. N Engl J Med 2008;359(11):1143–54.
(check this in PDF content)
2
Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277–300.
(check this in PDF content)
3
Brennan J.A., Boyle J.O., Koch W.M. et al. Association between cigarette smoking and mutation of the p53 gene in squamouscell carcinoma of the head and neck. N Engl J Med 1995;332(11):712–7.
(check this in PDF content)
4
Syrjanen K., Syrjanen S. and Pyrhonen S. Human papilloma virus (HPV) antigens in lesions of laryngeal squamous cell carcinomas. ORL J Otorhinolaryngol Relat Spec 1982;44(6):323–34.
(check this in PDF content)
5
Syrjanen K.J. and Surjanen S.M. Histological evidence for the presence of condylomatous epithelial lesions in association with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 1981;43(4):181–94.
(check this in PDF content)
6
Quintero K., Giraldo G.A., Uribe M.L. et al. Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia. Braz J Otorhinolaryngol 2013;79(3):375–81.
(check this in PDF content)
7
Curado M.P. and Boyle P. Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol. Curr Opin Oncol 2013;25(3):229–34.
(check this in PDF content)
8
Monsjou H.S., van Velthuysen M.L., van den Brekel M.W. et al. Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 2012;130(8):1806–12.
(check this in PDF content)
9
Smeets D., Ertmer K., Braunschweig T., Bolotin M.V. HPV in squamous epithelial lesions of the head and neck: different affection of different tumors. Tumors of the head and neck (in russian) 2011;1:61–5.
(check this in PDF content)
10
Thomas J. and Primeaux T. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 2012;16(2): 91–9.
(check this in PDF content)
11
National Cancer Registry Ireland Cancer Trends, 2011.10.
(check this in PDF content)
12
Kelley M.J., Otterson G.A. et al. CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines. Int J Cancer 1995;63(2):226–30.
(check this in PDF content)
13
Klaes R., Friedrich T., Spitkovsky D. et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92(2):276–84.
(check this in PDF content)
14
Mardis E.R. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008;9:387–402.
(check this in PDF content)
15
Lechner M., Frampton G., Fenton T. et al. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors. Genome Med 2013;5(5):49.
(check this in PDF content)
16
Stransky N., Egloff A.M., Tward A.D. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333(6046):1157–60.
(check this in PDF content)
17
Comprehensive genomic characterization of squamous cell lung cancers. Cancer Genome Atlas Research Network. Nature 2012;489(7417):519–25.
(check this in PDF content)
18
Bissada E., Abboud O., Abou Chacra Z. et al. Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes. Int J Otolaryngol 2013;2013:848021.
(check this in PDF content)
19
Leemans C.R., Braakhuis B.J. and Brakenhoff R.H. The molecular biology of head and neck cancer. Nat Rev Cancer
(check this in PDF content)
20
1;11(1):9–22. 20. Schlecht N.F., Brandwein-Gensler M., Nuovo G.J. et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 2011;24(10): 1295–305.
(check this in PDF content)
21
El-Naggar A.K. and Westra W.H. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency. Head Neck 2012;34(4):459–61.
(check this in PDF content)
22
Specenier P. and Vermorken J.B. Cetuximab: its unique place in head and neck cancer treatment. Biologics 2013;7:77–90.
(check this in PDF content)
23
Granata R., Miceli R., Orlandi E. et al. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol 2012;23(7):1832–7.
(check this in PDF content)
24
Chen Y.J., Rau K.M., Chien C.Y. et al. High p16 expression predicts a positive response to chemoradiotherapy in stage IVa/b head and neck squamous cell carcinoma. Asian Pac J Cancer Prev 2011;12(3):649–55.
(check this in PDF content)
25
Fischer C.A., Kampmann M., Zlobec I. et al. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010;21(10):1961–6.
(check this in PDF content)
26
Press O.W., Appelbaum F., Ledbetter J.A. et al. Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood 1987;69(2):584–91.
(check this in PDF content)
27
Newman S. Eribulin, a simplified ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer. Curr Opin Investig Drugs 2007;8(12):1057–66.
(check this in PDF content)
28
Owonikoko T.K. and Khuri F.R. Targeting the PI3K/AKT/mTOR Pathway. Am Soc Clin Oncol Educ Book 2013;2013:395–401.
(check this in PDF content)
29
Herzog A., Bian Y., Vander Broek R. et al. PI3K-mTOR inhibitor PF-04691502 anti-tumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin Cancer Res 2013 May 2.
(check this in PDF content)
30
Jiang T., Zhou C., Gu J. et al. Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA. Cancer Lett 2013 May 29.
(check this in PDF content)
31
Yabuuchi S., Pai S.G., Campbell N.R. et al. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett 2013;335(1):41–51.
(check this in PDF content)
32
Allay J.A., Steiner M.S., Zhang Y. et al. Adenovirus p16 gene therapy for prostate cancer. World J Urol 2000;18(2):111–20.
(check this in PDF content)
33
Sadeqzadeh E., de Bock C.E. and Thorne R.F. Sleeping Giants: Emerging Roles for the Fat Cadherins in Health and Disease. Med Res Rev 2013 May 29.
(check this in PDF content)
34
Ren M., Hong M., Liu G. et al. Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1. Oncol Rep 2013;29(6):2181–90.
(check this in PDF content)
35
Sweeny L., Liu Z., Lancaster W. et al. Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor. Laryngoscope 2012;122(7):1539–44.
(check this in PDF content)